A κ-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomy
- 1 January 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 107 (3) , 331-335
- https://doi.org/10.1016/0014-2999(85)90258-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomyEuropean Journal of Pharmacology, 1984
- Catatonic or hypotonic immobility induced in mice by intracerebroventricular injection of mu or kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradationLife Sciences, 1983
- Behavioural effect of adrenalectomy: Reversal by glucocorticoids or [D-ALA2, MET5]enkephalinamideEuropean Journal of Pharmacology, 1983
- Evidence that endogenous 6-(Arg or Lys)-opioid peptides can interact with κ-receptors as agonistsLife Sciences, 1982
- Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptorNature, 1982
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980
- Biochemical characterization of enkephalin-like immunoreactive peptides of adrenal glandsLife Sciences, 1980
- Multiple opiate receptorsTrends in Neurosciences, 1980
- Enkephalins interfere with acquisition of an active avoidance responseLife Sciences, 1980
- Depression: a new animal model sensitive to antidepressant treatmentsNature, 1977